Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2007 | 06-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,242 | 28,797 | 1,631 | N/A | N/A |
| Receivables | 103 | 112 | 108 | N/A | N/A |
| Other current assets | 2,641 | 2,724 | 31 | 0 | 0 |
| TOTAL | $20,986 | $31,633 | $1,770 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 382 | 44 | 29 | N/A | N/A |
| TOTAL | $382 | $44 | $29 | $N/A | $N/A |
| Total Assets | $21,368 | $31,677 | $1,799 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,213 | 724 | 1,039 | 0 | 0 |
| Other current liabilities | 162 | 153 | 101 | N/A | N/A |
| TOTAL | $1,375 | $877 | $1,141 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,375 | $877 | $1,141 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 108,540 | 118,631 | 92,056 | N/A | N/A |
| Retained earnings | -90,253 | -88,419 | -91,683 | N/A | N/A |
| Other shareholders' equity | 1,707 | 589 | 286 | 0 | 0 |
| TOTAL | $19,993 | $30,800 | $658 | $N/A | $N/A |
| Total Liabilities And Equity | $21,368 | $31,677 | $1,799 | $0 | $0 |